Ark. Goes After J&J For Risperdal Marketing, Costs

Law360, New York (November 21, 2007, 12:00 AM EST) -- The State of Arkansas has filed a lawsuit against Johnson & Johnson and subsidiaries Janssen Pharamceutica Inc. and Janssen LP alleging the companies illegally promoted the antipsychotic drug, Risperdal, to doctors for unnecessary medical conditions at a cost to the state.

The lawsuit, filed Tuesday in the Circuit Court of Pulaski County in Arkansas, also alleges that the companies are misrepresenting the risks of the medication to patients.

The suit seeks to recover the money the state paid to provide Risperdal to patients through Medicaid and...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.